343 related articles for article (PubMed ID: 21432613)
1. Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists.
Langen B; Dost R
Atten Defic Hyperact Disord; 2011 Mar; 3(1):1-12. PubMed ID: 21432613
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
[TBL] [Abstract][Full Text] [Related]
3. Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
Mc Fie S; Sterley TL; Howells FM; Russell VA
Brain Res; 2012 Jul; 1467():91-103. PubMed ID: 22658977
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder.
Kawaura K; Karasawa J; Chaki S; Hikichi H
Behav Brain Res; 2014 Aug; 270():349-56. PubMed ID: 24882610
[TBL] [Abstract][Full Text] [Related]
6. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
van den Bergh FS; Bloemarts E; Chan JS; Groenink L; Olivier B; Oosting RS
Pharmacol Biochem Behav; 2006 Mar; 83(3):380-90. PubMed ID: 16580713
[TBL] [Abstract][Full Text] [Related]
7. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
Howells FM; Russell VA
Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of a selective dopamine D1-like receptor agonist on motor activity and c-fos expression in the frontal-striatal circuitry of SHR and Wistar-Kyoto rats.
Diaz Heijtz R; Castellanos FX
Behav Brain Funct; 2006 May; 2():18. PubMed ID: 16729883
[TBL] [Abstract][Full Text] [Related]
9. Spontaneously hypertensive and Wistar Kyoto rats differ in delayed matching-to-place performance and response to dietary long-chain polyunsaturated fatty acids.
Clements KM; Girard TA; Xing HC; Wainwright PE
Dev Psychobiol; 2003 Jul; 43(1):57-69. PubMed ID: 12794779
[TBL] [Abstract][Full Text] [Related]
10. Altered pre- and postsynaptic dopamine receptor functions in spontaneously hypertensive rat: an animal model of attention-deficit hyperactivity disorder.
Fujita S; Okutsu H; Yamaguchi H; Nakamura S; Adachi K; Saigusa T; Koshikawa N
J Oral Sci; 2003 Jun; 45(2):75-83. PubMed ID: 12930130
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
Umehara M; Ago Y; Kawanai T; Fujita K; Hiramatsu N; Takuma K; Matsuda T
Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
[TBL] [Abstract][Full Text] [Related]
12. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].
Ueno K; Togashi H; Yoshioka M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):47-55. PubMed ID: 12690641
[TBL] [Abstract][Full Text] [Related]
13. Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro.
Yoon SY; dela Peña I; Kim SM; Woo TS; Shin CY; Son KH; Park H; Lee YS; Ryu JH; Jin M; Kim KM; Cheong JH
Arch Pharm Res; 2013 Jan; 36(1):134-40. PubMed ID: 23371806
[TBL] [Abstract][Full Text] [Related]
14. Early androgen treatment influences the pattern and amount of locomotion activity differently and sexually differentially in an animal model of ADHD.
Li JS; Huang YC
Behav Brain Res; 2006 Nov; 175(1):176-82. PubMed ID: 16979765
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine or behavioral effects of acute or chronic emotional stress in Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rats.
Roman O; Seres J; Pometlova M; Jurcovicova J
Endocr Regul; 2004 Dec; 38(4):151-5. PubMed ID: 15841794
[TBL] [Abstract][Full Text] [Related]
16. Spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats differ in performance on a win-shift task in the water radial arm maze.
Clements KM; Wainwright PE
Behav Brain Res; 2006 Feb; 167(2):295-304. PubMed ID: 16293322
[TBL] [Abstract][Full Text] [Related]
17. N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder.
Jensen V; Rinholm JE; Johansen TJ; Medin T; Storm-Mathisen J; Sagvolden T; Hvalby O; Bergersen LH
Neuroscience; 2009 Jan; 158(1):353-64. PubMed ID: 18571865
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity to delay of reinforcement in two animal models of attention deficit hyperactivity disorder (ADHD).
Sutherland KR; Alsop B; McNaughton N; Hyland BI; Tripp G; Wickens JR
Behav Brain Res; 2009 Dec; 205(2):372-6. PubMed ID: 19616039
[TBL] [Abstract][Full Text] [Related]
19. Spatial learning/memory and social and nonsocial behaviors in the spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rat strains.
Ferguson SA; Cada AM
Pharmacol Biochem Behav; 2004 Mar; 77(3):583-94. PubMed ID: 15006470
[TBL] [Abstract][Full Text] [Related]
20. Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder.
Kantak KM; Singh T; Kerstetter KA; Dembro KA; Mutebi MM; Harvey RC; Deschepper CF; Dwoskin LP
Behav Neurosci; 2008 Apr; 122(2):340-57. PubMed ID: 18410173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
